Skip to main content
Top
Published in: Child's Nervous System 10/2019

01-10-2019 | Craniosynostosis | Special Annual Issue

Chiari I malformation in defined genetic syndromes in children: are there common pathways?

Authors: Veronica Saletti, Ilaria Viganò, Giulia Melloni, Chiara Pantaleoni, Ignazio Gaspare Vetrano, Laura Grazia Valentini

Published in: Child's Nervous System | Issue 10/2019

Login to get access

Abstract

Purpose

Chiari malformation type I (CMI) is a common pediatric neurologic anomaly that can be associated with a variety of genetic disorders; however, it is not always clear whether the observed associations are real or random. The knowledge of the real associations could provide useful guidance to clinicians. Furthermore, it could be of help to better understand the still unknown genetic etiology of CMI.

Methods

With the aim of implementing such insights, we retrospectively reviewed clinical, neuroradiological, and genetic data of patients harboring CMI evaluated at the Child Neurology Unit of our institution between January 2008 and December 2018.

Results

The cohort consists of 205 patients (111 males and 94 females), with a mean age at diagnosis of 6.3 years (range 0–18 years). 188 patients completed an average follow-up period of 5.2 years (range one month–18 years). Mean age at last assessment was 11.4 years (range nine months–23 years). 127 (62%) children have been classified as syndromic due to the presence of neurodevelopmental disorders, phenotypic anomalies, or malformations. Among syndromic CMI children, a molecular diagnosis was identified in 35/127 (27.6%) (20 males and 15 females). The most common diagnoses were syndromic craniosynostosis in 8/35 children (22.9%), among which sevenare FGFR-related and one ERF-related craniosynostosis; disorders of the RAS/MAPK pathway, termed RASopathies or RAS/MAPK syndromes in 9/35 (25.7%); disorders of the PTEN-PI3K/AKT signal transduction cascade, termed PTENopathies in 3/35 children (8.6%); and chromosomal rearrangements in 6/35 patients (17.1%), two of whom with del16p11.2.

Conclusions

We polarized our attention on the defined genetic diagnoses focusing not only on the phenotypic hallmarks but also on the phenotypic overlapping features. In addition, we discussed the pathophysiological mechanisms leading to progressive cerebellar ectopia and the involved molecular pathways. Along with the recent literature evidence, we suppose that interactions between FGFR and RAS/MAPK pathway and between RAS/MAPK and PTEN-PI3K/AKT pathways could explain some phenotypic overlapping features and could have a significant role in the pathogenesis of CMI.
Literature
12.
go back to reference Ejarque I, Millán-Salvador JM, Oltra S, Pesudo-Martínez JV, Beneyto M, Pérez-Aytés A (2015) Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway. Rev Neurol 60(9):408–412PubMed Ejarque I, Millán-Salvador JM, Oltra S, Pesudo-Martínez JV, Beneyto M, Pérez-Aytés A (2015) Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway. Rev Neurol 60(9):408–412PubMed
15.
go back to reference Glass GE, O'Hara J, Canham N, Cilliers D, Dunaway D, Fenwick AL, Jeelani NO, Johnson D, Lester T, Lord H, Morton JEV, Nishikawa H, Noons P, Schwiebert K, Shipster C, Taylor-Beadling A, Twigg SRF, Vasudevan P, Wall SA, Wilkie AOM, Wilson LC (2019) ERF-related craniosynostosis: the phenotypic and developmental profile of a new craniosynostosis syndrome. Am J Med Genet A 179(4):615–627. https://doi.org/10.1002/ajmg.a.61073 CrossRefPubMedPubMedCentral Glass GE, O'Hara J, Canham N, Cilliers D, Dunaway D, Fenwick AL, Jeelani NO, Johnson D, Lester T, Lord H, Morton JEV, Nishikawa H, Noons P, Schwiebert K, Shipster C, Taylor-Beadling A, Twigg SRF, Vasudevan P, Wall SA, Wilkie AOM, Wilson LC (2019) ERF-related craniosynostosis: the phenotypic and developmental profile of a new craniosynostosis syndrome. Am J Med Genet A 179(4):615–627. https://​doi.​org/​10.​1002/​ajmg.​a.​61073 CrossRefPubMedPubMedCentral
19.
go back to reference Gripp KW, Hopkins E, Sol-Church K, Stabley DL, Axelrad ME, Doyle D, Dobyns WB, Hudson C, Johnson J, Tenconi R, Graham GE, Sousa AB, Heller R, Piccione M, Corsello G, Herman GE, Tartaglia M, Lin AE (2011) Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C. Am J Med Genet A 155A(4):706–716. https://doi.org/10.1002/ajmg.a.33884 CrossRefPubMed Gripp KW, Hopkins E, Sol-Church K, Stabley DL, Axelrad ME, Doyle D, Dobyns WB, Hudson C, Johnson J, Tenconi R, Graham GE, Sousa AB, Heller R, Piccione M, Corsello G, Herman GE, Tartaglia M, Lin AE (2011) Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C. Am J Med Genet A 155A(4):706–716. https://​doi.​org/​10.​1002/​ajmg.​a.​33884 CrossRefPubMed
21.
26.
go back to reference Kerr B, Delrue MA, Sigaudy S, Perveen R, Marche M, Burgelin I, Stef M, Tang B, Eden OB, O'Sullivan J, De Sandre-Giovannoli A, Reardon W, Brewer C, Bennett C, Quarell O, M'Cann E, Donnai D, Stewart F, Hennekam R, Cavé H, Verloes A, Philip N, Lacombe D, Levy N, Arveiler B, Black G (2006) Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet 43(5):401–405. https://doi.org/10.1136/jmg.2005.040352 CrossRefPubMedPubMedCentral Kerr B, Delrue MA, Sigaudy S, Perveen R, Marche M, Burgelin I, Stef M, Tang B, Eden OB, O'Sullivan J, De Sandre-Giovannoli A, Reardon W, Brewer C, Bennett C, Quarell O, M'Cann E, Donnai D, Stewart F, Hennekam R, Cavé H, Verloes A, Philip N, Lacombe D, Levy N, Arveiler B, Black G (2006) Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet 43(5):401–405. https://​doi.​org/​10.​1136/​jmg.​2005.​040352 CrossRefPubMedPubMedCentral
32.
go back to reference McGaughran J, Aftimos S, Jefferies C, Winship I (2001) Clinical phenotypes of nine cases of Kabuki syndrome from New Zealand. Clin Dysmorphol 10(4):257–262CrossRefPubMed McGaughran J, Aftimos S, Jefferies C, Winship I (2001) Clinical phenotypes of nine cases of Kabuki syndrome from New Zealand. Clin Dysmorphol 10(4):257–262CrossRefPubMed
36.
go back to reference Mirzaa GM, Conway RL, Gripp KW, Lerman-Sagie T, Siegel DH, deVries LS, Lev D, Kramer N, Hopkins E, Graham JM Jr, Dobyns WB (2012) Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A 158A:269–291. https://doi.org/10.1002/ajmg.a.34402 CrossRefPubMed Mirzaa GM, Conway RL, Gripp KW, Lerman-Sagie T, Siegel DH, deVries LS, Lev D, Kramer N, Hopkins E, Graham JM Jr, Dobyns WB (2012) Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A 158A:269–291. https://​doi.​org/​10.​1002/​ajmg.​a.​34402 CrossRefPubMed
40.
go back to reference Owen JP, Bukshpun P, Pojman N, Thieu T, Chen Q, Lee J, D’Angelo D, Glenn OA, Hunter JV, Berman JI, Roberts TP, Buckner R, Nagarajan SS, Mukherjee P, Sherr EH (2018) Brain MR imaging findings and associated outcomes in carriers of the reciprocal copy number variation at 16p11.2. Radiology 286(1):217–226. https://doi.org/10.1148/radiol.2017162934 CrossRefPubMed Owen JP, Bukshpun P, Pojman N, Thieu T, Chen Q, Lee J, D’Angelo D, Glenn OA, Hunter JV, Berman JI, Roberts TP, Buckner R, Nagarajan SS, Mukherjee P, Sherr EH (2018) Brain MR imaging findings and associated outcomes in carriers of the reciprocal copy number variation at 16p11.2. Radiology 286(1):217–226. https://​doi.​org/​10.​1148/​radiol.​2017162934 CrossRefPubMed
42.
go back to reference Pozetti M, Belsuzarri TA, Belsuzarri NC, Seixas NB, Araujo JF (2016) Neurofibromatosis type 1 and Chiari type 1 malformation: a case report and literature review of a rare association. Surg Neurol Int 7(Suppl 16):S469–S472PubMedPubMedCentral Pozetti M, Belsuzarri TA, Belsuzarri NC, Seixas NB, Araujo JF (2016) Neurofibromatosis type 1 and Chiari type 1 malformation: a case report and literature review of a rare association. Surg Neurol Int 7(Suppl 16):S469–S472PubMedPubMedCentral
44.
48.
go back to reference Speer MC, George TM, Enterline DS, Franklin A, Wolpert CM, Milhorat TH (2000) A genetic hypothesis for Chiari I malformation with or without syringomyelia. Neurosurg Focus 8(3):E12CrossRefPubMed Speer MC, George TM, Enterline DS, Franklin A, Wolpert CM, Milhorat TH (2000) A genetic hypothesis for Chiari I malformation with or without syringomyelia. Neurosurg Focus 8(3):E12CrossRefPubMed
49.
go back to reference Steinman KJ, Spence SJ, Ramocki MB, Proud MB, Kessler SK, Marco EJ, Green Snyder L, D'Angelo D, Chen Q, Chung WK, Sherr EH, Simons VIP Consortium (2016) 16p11.2 deletion and duplication: characterizing neurologic phenotypes in a large clinically ascertained cohort. Am J Med Genet A 170(11):2943–2955. https://doi.org/10.1002/ajmg.a.37820 CrossRefPubMed Steinman KJ, Spence SJ, Ramocki MB, Proud MB, Kessler SK, Marco EJ, Green Snyder L, D'Angelo D, Chen Q, Chung WK, Sherr EH, Simons VIP Consortium (2016) 16p11.2 deletion and duplication: characterizing neurologic phenotypes in a large clinically ascertained cohort. Am J Med Genet A 170(11):2943–2955. https://​doi.​org/​10.​1002/​ajmg.​a.​37820 CrossRefPubMed
51.
go back to reference Takenouchi T, Sakamoto Y, Miwa T, Torii C, Kosaki R, Kishi K, Takahashi T, Kosaki K (2014) Severe craniosynostosis with Noonan syndrome phenotype associated with SHOC2 mutation: clinical evidence of crosslink between FGFR and RAS signaling pathways. Am J Med Genet A 164:2869–2872. https://doi.org/10.1002/ajmg.a.36705 CrossRef Takenouchi T, Sakamoto Y, Miwa T, Torii C, Kosaki R, Kishi K, Takahashi T, Kosaki K (2014) Severe craniosynostosis with Noonan syndrome phenotype associated with SHOC2 mutation: clinical evidence of crosslink between FGFR and RAS signaling pathways. Am J Med Genet A 164:2869–2872. https://​doi.​org/​10.​1002/​ajmg.​a.​36705 CrossRef
58.
go back to reference Twigg SR, Vorgia E, McGowan SJ, Peraki I, Fenwick AL, Sharma VP, Allegra M, Zaragkoulias A, Sadighi Akha E, Knight SJ, Lord H, Lester T, Izatt L, Lampe AK, Mohammed SN, Stewart FJ, Verloes A, Wilson LC, Healy C, Sharpe PT, Hammond P, Hughes J, Taylor S, Johnson D, Wall SA, Mavrothalassitis G, Wilkie AO (2013) Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat Genet 45(3):308–313. https://doi.org/10.1038/ng.2539 CrossRefPubMedPubMedCentral Twigg SR, Vorgia E, McGowan SJ, Peraki I, Fenwick AL, Sharma VP, Allegra M, Zaragkoulias A, Sadighi Akha E, Knight SJ, Lord H, Lester T, Izatt L, Lampe AK, Mohammed SN, Stewart FJ, Verloes A, Wilson LC, Healy C, Sharpe PT, Hammond P, Hughes J, Taylor S, Johnson D, Wall SA, Mavrothalassitis G, Wilkie AO (2013) Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat Genet 45(3):308–313. https://​doi.​org/​10.​1038/​ng.​2539 CrossRefPubMedPubMedCentral
Metadata
Title
Chiari I malformation in defined genetic syndromes in children: are there common pathways?
Authors
Veronica Saletti
Ilaria Viganò
Giulia Melloni
Chiara Pantaleoni
Ignazio Gaspare Vetrano
Laura Grazia Valentini
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 10/2019
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-019-04319-5

Other articles of this Issue 10/2019

Child's Nervous System 10/2019 Go to the issue